Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
Siti Aishah Sulaiman, Nor I A Muhsin, Rahman Jamal
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 103
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Haiou Li, Yunjiao Zhou, Haizhou Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 90
Long non‐coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes
Hao Wang, Youde Cao, Liqing Shu, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 2, pp. 1399-1412
Open Access | Times Cited: 87
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway
Ahmed Samy, Mohamed A. Kandeil, Dina Sabry, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 7
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
Olfa Khalifa, Khaoula Errafii‬, Nayla S. Al-Akl, et al.
Disease Markers (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 55
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Alix Bruneau, Jana Hundertmark, Adrien Guillot, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism
Yuhan Li, Yansong Luan, Jianning Li, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 1057-1074
Closed Access | Times Cited: 49
Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 40
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
E. Klieser, Christian Mayr, Tobias Kiesslich, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5266-5266
Open Access | Times Cited: 46
Interactions Among Non-Coding RNAs in Diabetic Nephropathy
Tamil Selvi Loganathan, Siti Aishah Sulaiman, Nor Azian Abdul Murad, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 44
Role of long non‐coding RNAs in adipogenesis: State of the art and implications in obesity and obesity‐associated diseases
Federica Rey, Valentina Urrata, Luisa Gilardini, et al.
Obesity Reviews (2021) Vol. 22, Iss. 7
Open Access | Times Cited: 35
M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way
Kai Li, Zi-Yang Peng, Shan Gao, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 33
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access
Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1494-1494
Open Access | Times Cited: 35
Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2
Abdullah S. Shatoor, Suliman Al Humayed, Hussain Almohiy
Journal of Physiology and Biochemistry (2021) Vol. 78, Iss. 1, pp. 151-168
Closed Access | Times Cited: 27
Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus
Biomedicines (2022) Vol. 11, Iss. 1, pp. 106-106
Open Access | Times Cited: 19
mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease
Marwa Matboli, Shaimaa H. Gadallah, Wafaa M. Rashed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6770-6770
Open Access | Times Cited: 26
Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model
Shaimaa H. Gadallah, Sanaa Eissa, Hala Ghanem, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 140, pp. 111781-111781
Open Access | Times Cited: 23
Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease
Yuping Zeng, He He, Zhenmei An
Disease Markers (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 17
Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
Reda Albadawy, Amany Helmy Hasanin, Sara H. A. Agwa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10148-10148
Open Access | Times Cited: 16
LncRNA Gm5091 alleviates alcoholic hepatic fibrosis by sponging miR‐27b/23b/24 in mice
Bo Zhou, Wenwen Yuan, Xinping Li
Cell Biology International (2018) Vol. 42, Iss. 10, pp. 1330-1339
Closed Access | Times Cited: 28
Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data
Xinlu Yuan, Jianjun Diao, Anqing Du, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 24
The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice
Valentina Cossiga, Vincenzo Lembo, Cecilia Nigro, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1281-1281
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top